2型糖尿病中的甲福明:证据表明它对虚弱和肉症的有益作用
Elisavet E Pyrgioti1, Nikolaos D Karakousis2, Petros N Georgakopoulos3
1Pharmacist, Private Practice, Athens, Greece.
Current diabetes reviews
|July 27, 2023
概括
甲福明可以在2型糖尿病 (T2DM) 中提供对脆弱性和肉症的保护. 然而,目前的证据是不一致的,需要进一步的研究来确认甲福明在管理这些条件的作用.
科学领域:
- 老年学是一门学科.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 经常与虚弱综合征和肉症有关,导致不良健康结果.
- 甲福明是T2DM的第一线药物治疗,新兴的研究表明,除了血糖控制之外,还有潜在的益处.
- T2DM,虚弱,肉症和甲胺之间的相互作用需要进行全面的审查,以了解潜在的治疗作用.
研究的目的:
- 审查目前关于T2DM患者脆弱综合征,肉症和甲胺之间的相互作用的证据.
- 探索甲胺对脆弱性和肉症的发展或进展的潜在保护作用.
- 识别知识上的差距,并建议未来的研究方向.
主要方法:
- 这项研究是对现有文献的叙述性审查.
- 通过搜索主要的生物医学数据库,确定了相关的研究.
- 该审查综合了在T2DM的背景下关于甲福明对脆弱性和肉症的影响的研究结果.
主要成果:
- 新出现的证据表明,甲福明可能在T2DM中对脆弱性和肉症都有保护作用.
- 然而,现有的研究提出了不一致的结果,关于甲福明的有效性和机制的潜在好处.
- 甲福尔明对这些疾病的确切影响仍需最终确定.
结论:
- 目前的证据基础不足以最终得出结论,是否甲福明可以改善T2DM中的脆弱性和/或肉症.
- 进一步的高质量,精心设计的临床试验至关重要,以阐明甲福尔在减轻该患者队列中的脆弱性和肉症方面的确切作用.
- 了解这种关系可能会导致优化治疗策略来管理T2DM并发症并改善老年患者的治疗结果.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
234
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
234
01:36Carbohydrate Metabolism
11.3K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K
01:15Diabetes: Management and Pharmacotherapy
317
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
317
01:15Diabetes: Symptoms, Diagnosis, and Complications
595
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
595
01:16Insulin: Dosing Regimen and Adverse Effects
211
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
211
01:19Overview of Carbohydrate Metabolism
1.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.2K